BIOCRYL RAPIDE™ Biocomposite Material

BIOCRYL RAPIDE™ is a biocomposite material. A proprietary Micro-Particle Dispersion (MPD) manufacturing process provides a homogenous dispersion of the composite materials*, while ensuring β-TCP is in close apposition with the surrounding bone tissues.

* Non-homogeneous composites may result in a material with compromised or variable strength properties due to stress risers within the material.

One Material, Multiple Implant Options

DePuy Synthes Mitek Sports Medicine offers a BIOCRYL RAPIDE™ Family of Implants consisting of suture anchors and interference screws.

BioComposite 70% PLGA/30% β-TCP

Resorbable Co-Polymer of Poly-L-Lactic Acid and Poly-Glycolic Acid (PLGA) plus β-TriCalcium Phosphate (β-TCP) displayed faster absorption than L-PLA in vitro.¹

Resorbable & May Promote Bony Ingrowth^2,3

In long-term human imaging studies, BIOCRYL RAPIDE™ biocomposite material (Poly-lactide co-glycolide/beta-TCP) has been shown to absorb and promote bone formation within the implant profile.²

Pure Medical Grade β-TCP

β-TCP without added fillers.

Micro Particle Dispersion Technology (MPD)

MPD is a proprietary manufacturing process that ensures a homogenous blend of β-TCP and PLGA particles. Dispersion of the composite particles is critical to the material properties.¹

Radiopaque

β-TCP enables the implant to be visible on x-ray.

Request Sales Rep

If you wish to learn more about this product, submit a request and a representative of DePuy Synthes will be in touch shortly.

Request Brochure

If you require a printed or digital brochure or surgical technique for this product, submit your request and we will send it to you.

Other Requests

Have a different kind of query? Simply fill out the details of your request and we will get back to you as soon as possible.

References

1.   Poandl T., et. al. “A New Faster-Absorbing Biocomposite Material: Long-Term In-Vivo Tissue Reaction and Absorption.” Poster presentation, Spring AANA, May 2005. Animal and bench top studies may not be indicative of clinical performance.
2.   Barber FA, Dockery WD, Hrnack, SA, Long-Term Degradation of a Poly-Lactide Co-Glycolide/β-Tricalcium Phosphate Biocomposite Interference screw. Arthroscopy, Vol 27, No. 5, pp.637-643 (2011).
3.   Barber, FA, et al. “Biocomposite Implants Composed of Poly (Lactide-co-Glycolide)/β-Tricalcium Phosphate: Systematic Review of Imaging, Complication, and Performance Outcomes.” Arthroscopy; 33(3):683-689.

Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.

109199-210315

© Johnson & Johnson Medical Limited 2021. All Rights Reserved.
This site is published by the DePuy Synthes Companies, which are solely responsible for its content.
This site is for visitors from United Kingdom.
The third party trademarks used herein are trademarks of their respective owners.